Your browser doesn't support javascript.
Viral strategies for circumventing p53: the case of severe acute respiratory syndrome coronavirus.
Cardozo, Camila Martin; Hainaut, Pierre.
  • Cardozo CM; Institute for Advanced Biosciences, Inserm 1209 CNRS 5309 University Grenoble-Alpes, Grenoble, France.
Curr Opin Oncol ; 33(2): 149-158, 2021 03 01.
Article in English | MEDLINE | ID: covidwho-1066437
ABSTRACT
PURPOSE OF REVIEW Virtually all viruses have evolved molecular instruments to circumvent cell mechanisms that may hamper their replication, dissemination, or persistence. Among these is p53, a key gatekeeper for cell division and survival that also regulates innate immune responses. This review summarizes the strategies used by different viruses and discusses the mechanisms deployed by SARS-CoV to target p53 activities. RECENT

FINDINGS:

We propose a typology for the strategies used by different viruses to address p53 functions hit and run (e.g. IAV, ZIKV), hide and seek (e.g. HIV1), kidnap and exploit (e.g. EBV, HSV1), dominate and suppress (e.g. HR HPV). We discuss the mechanisms by which SARS nsp3 protein targets p53 for degradation and we speculate on the significance for Covid-19 pathogenesis and risk of cancer.

SUMMARY:

p53 may operate as an intracellular antiviral defense mechanism. To circumvent it, SARS viruses adopt a kidnap and exploit strategy also shared by several viruses with transforming potential. This raises the question of whether SARS infections may make cells permissive to oncogenic DNA damage.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / SARS-CoV-2 / COVID-19 Type of study: Prognostic study Limits: Animals / Humans Language: English Journal: Curr Opin Oncol Journal subject: Neoplasms Year: 2021 Document Type: Article Affiliation country: CCO.0000000000000713

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / SARS-CoV-2 / COVID-19 Type of study: Prognostic study Limits: Animals / Humans Language: English Journal: Curr Opin Oncol Journal subject: Neoplasms Year: 2021 Document Type: Article Affiliation country: CCO.0000000000000713